The effect of glutaraldehyde adulteration of urine specimens on Syva EMIT II drugs-of-abuse assays

被引：23
|
作者：
George, S
Braithwaite, RA
机构：
[1] Regional Laboratory for Toxicology, City Hospital NHS Trust, Birmingham B18 7QH, Dudley Road
来源：
JOURNAL OF ANALYTICAL TOXICOLOGY | 1996年 / 20卷 / 03期
关键词：
D O I：
10.1093/jat/20.3.195
中图分类号：
O65 [分析化学];
学科分类号：
070302 ; 081704 ;
摘要：
The effect of glutaraldehyde (the active component of 'UrinAid') on Syva EMIT II drugs-of-abuse screening assays was studied. It was found that, dependent on the assay involved, concentrations of between 0.75 and 2.00% (v/v) of glutaraldehyde in urine could give rise to false-negative screening results. A simple method for identifying urine specimens that have been adulterated with glutaraldehyde, based on final absorbance rate readings (dA/min), is proposed.
引用
收藏
页码：195 / 196
页数：2
相关论文
共 50 条
  • [21] EVALUATION OF THE TRIAGE SYSTEM FOR EMERGENCY DRUGS-OF-ABUSE TESTING IN URINE
    WU, AHB
    WONG, SS
    JOHNSON, KG
    CALLIES, J
    SHU, DX
    DUNN, WE
    WONG, SHY
    JOURNAL OF ANALYTICAL TOXICOLOGY, 1993, 17 (04) : 241 - 245
  • [22] THE ADAPTATION OF THE SYVA ASSAYS FOR DRUGS OF ABUSE ON THE OLYMPUS REPLY LAB ANALYZER
    BALDWIN, JR
    PLESHER, CJ
    LENZO, A
    CLINICAL CHEMISTRY, 1989, 35 (06) : 1174 - 1175
  • [23] External quality assessment of syva emit and Abbott TDx II assays for methotrexate in serum
    Wilson, JF
    Tsanaclis, LM
    Barnett, K
    THERAPEUTIC DRUG MONITORING, 1996, 18 (06) : 721 - 723
  • [24] APPLICATION OF THE EMIT DRUGS OF ABUSE (DAU) ASSAYS TO THE ETS SYSTEM
    IZUTSU, A
    KENNEDY, P
    HAMMAD, N
    AMBROCIO, E
    QUINN, RT
    MASOVER, B
    COLLINS, C
    BARTLETT, S
    BRADY, A
    CLINICAL CHEMISTRY, 1987, 33 (06) : 975 - 976
  • [25] Vitamin B2 interference with TDx drugs-of-abuse assays
    Kunsman, GW
    Levine, B
    Smith, ML
    JOURNAL OF FORENSIC SCIENCES, 1998, 43 (06) : 1225 - 1227
  • [26] The effects of adulterants and selected ingested compounds on drugs-of-abuse testing in urine
    Dasgupta, Amitava
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2007, 128 (03) : 491 - 503
  • [27] Morphine formation from ethylmorphine: Implications for drugs-of-abuse testing in urine
    Popa, C
    Beck, O
    Brodin, K
    JOURNAL OF ANALYTICAL TOXICOLOGY, 1998, 22 (02) : 142 - 147
  • [28] Evaluation of DuPont Drine drugs-of-abuse assays on Dimension(R) AR.
    Song, H
    Wong, SS
    CLINICAL CHEMISTRY, 1996, 42 (06) : 266 - 266
  • [29] Analytical performance validation of Microgenics CEDIA drugs-of-abuse assays on the Advia 1650
    Stone, JA
    Chen, K
    Gross, S
    Magcauas, R
    Brown, V
    Haller, C
    CLINICAL CHEMISTRY, 2004, 50 (06) : A127 - A127
  • [30] Section II - Recommendations on analytical assays & reporting issues for drugs-of-abuse testing & breath-alochol analysis
    Broussard, LA
    Hoffman, RS
    Kwong, TC
    McKay, C
    Moyer, TP
    Otten, EJ
    Wax, P
    Welch, SL
    CLINICAL CHEMISTRY, 2001, 47 (06) : S29 - S30
12345